Detalhe da pesquisa
1.
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial.
Int J Cancer
; 142(3): 618-628, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28940389
2.
The Impact of a Hepatobiliary Multidisciplinary Team Assessment in Patients with Colorectal Cancer Liver Metastases: A Population-Based Study.
Oncologist
; 22(9): 1067-1074, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550028
3.
The Late Effects of Cancer Treatment on Female Fertility and the Current Status of Fertility Preservation-A Narrative Review.
Life (Basel)
; 13(5)2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240840
4.
Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial.
Clin Cancer Res
; 29(3): 532-540, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449695
5.
Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis.
JAMA Oncol
; 8(10): 1438-1446, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006625
6.
Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.
Breast Cancer Res Treat
; 130(2): 553-60, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21617918
7.
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(9): 1360-1367, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165503
8.
Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial.
Int J Radiat Oncol Biol Phys
; 106(5): 958-967, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987957
9.
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer.
Oncoimmunology
; 7(9): e1466017, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30228933
10.
First results of the preoperative accelerated partial breast irradiation (PAPBI) trial.
Radiother Oncol
; 114(3): 322-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701298